Rachel E Sobel (R E Sobel)

Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2023
Publications (10 Years): 8

Top Venues

Drug safety

Pharmacoepidemiology and drug safety

International journal of clinical practice

International journal of clinical pharmacy

United BioSource Corp

This page only lists publications with an associated author ORCID identifier.

Affiliation History

United BioSource Corp Nov 18 2019

United States

Vice President, Epidemiology and Strategic Engagement

Publications

Lesley H Curtis, Oriol Solà-Morales, Julien Heidt, Patrick Saunders-Hastings, Laura Walsh, Deborah Casso, Susan Oliveria, Tiffany Mercado, Robbert Zusterzeel, Rachel E Sobel, Jessica J Jalbert, Vera Mastey, James Harnett, Ruben G W Quek
Regulatory and HTA Considerations for Development of Real-World Data Derived External Controls. Clinical pharmacology and therapeutics (2023)
Joanna Lem, Janine Collins, Terry Maguire, Rachel E Sobel
A web-based survey of UK pharmacists to assess the effectiveness of Viagra Connect ® additional risk minimisation measures. International journal of clinical pharmacy 44 (3) (2022)
Joanna Lem, Muhammad Younus, Jalal A Aram, Shahrzad Moosavi, Klaus Freivogel, Anne Lewis, Rachel E Sobel
Evaluation of the Effectiveness of Additional Risk Minimization Measures for Voriconazole in the EU: Findings and Lessons Learned from a Healthcare Professional Survey. Pharmaceutical medicine 33 (2) (2020)
Rachel E Sobel, William Blackwell, David M Fram, Andrew Bate
A Novel Approach to Visualize Risk Minimization Effectiveness: Peeping at the 2012 UK Proton Pump Inhibitor Label Change Using a Rapid Cycle Analysis Tool. Drug safety 42 (11) (2020)
Christine A Radawski, Tarek A Hammad, Susan Colilla, Paul Coplan, Kenneth Hornbuckle, Emily Freeman, Meredith Y Smith, Rachel E Sobel, Priya Bahri, Ariel E Arias, Dimitri Bennett
The utility of real-world evidence for benefit-risk assessment, communication, and evaluation of pharmaceuticals: Case studies. Pharmacoepidemiology and drug safety 29 (12) (2020)
Rachel E Sobel, Andrew Bate, Robert F Reynolds
Real World Evidence: Time for a Switch? Drug safety 41 (12) (2018)
Rachel E Sobel, Andrew Bate, James Marshall, Kevin Haynes, Nandini Selvam, Vinit Nair, Gregory Daniel, Jeffrey S Brown, Robert F Reynolds
Do FDA label changes work? Assessment of the 2010 class label change for proton pump inhibitors using the Sentinel System's analytic tools. Pharmacoepidemiology and drug safety 27 (3) (2018)
K Asomaning, S Abramsky, Q Liu, X Zhou, Rachel E Sobel, S Watt
Pregabalin prescriptions in the United Kingdom: a drug utilisation study of The Health Improvement Network (THIN) primary care database. International journal of clinical practice 70 (5) (2016)

Rachel E Sobel.css-eqlu8i{font-size:small;padding-left:4px;} (R E Sobel)

Publication Activity (10 Years)

Top Topics

Top Venues

Rachel E Sobel (R E Sobel)